Centrica plc (LON:CNA) Analysts Boost Revenue Estimates

Analysts have upgraded Centrica's revenue estimates, with consensus now at £23b in 2025, an 18% increase from the past 12 months. The most recent consensus forecast for the company's revenue is £23b in 2025, with losses expected to disappear over the next year or so. The analysts' price target remains at £1.84, with the uplift in sales not expected to greatly contribute to Centrica's valuation in the near term.

Analysts have upgraded Centrica's revenue estimates, with consensus now at £23b in 2025, representing an 18% increase from the past 12 months [2]. This positive outlook is driven by improved financial performance, including better profitability and cash flow metrics in 2024 [2]. The most recent consensus forecast for the company's revenue is £23b in 2025, with losses expected to disappear over the next year or so. Despite the uplift in sales, analysts do not expect this to significantly contribute to Centrica's valuation in the near term, with the price target remaining at £1.84 [2].

Centrica's overall stock score is primarily influenced by its improved financial performance and positive technical analysis trends. However, valuation concerns persist due to the negative P/E ratio [2]. The company's corporate actions, such as share buybacks and strategic investments, reflect a commitment to shareholder value [2].

The analysts' upgrade in revenue estimates is a positive sign for Centrica, indicating a recovery in the company's financial health. However, investors should closely monitor the company's ability to sustain this growth and manage its valuation effectively.

References:
[1] https://www.nasdaq.com/articles/exponent-expo-q2-revenue-rises-1
[2] https://www.tipranks.com/stocks/gb:cna/forecast